open access
A comment on the paper ‘Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors’ by Sapko et al.
Affiliations- Chair and Department of Neurology, Jaczewskiego 8, 20-954 Lublin, Poland
open access
Abstract
Abstract
About this articleTitle
A comment on the paper ‘Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors’ by Sapko et al.
Journal
Neurologia i Neurochirurgia Polska
Issue
Article type
Response to Letter to the Editors
Pages
117
Published online
2020-10-07
Page views
683
Article views/downloads
585
DOI
Pubmed
Bibliographic record
Neurol Neurochir Pol 2021;55(1):117.
Authors
Klaudia Sapko
Anna Jamroz-Wiśniewska
Michał Marciniec
Marcin Kulczyński
Anna Szczepańska-Szerej
Konrad Rejdak
References (6)- Lewczuk P, Kornhuber J, Mroczko BA, et al. comment to the paper "Biomarkers in Multiple Sclerosis" by Sapko. Neurol Neurochir Pol. ; 2020: 55.
- Sapko K, Jamroz-Wiśniewska A, Marciniec M, et al. Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors. Neurol Neurochir Pol. 2020; 54(3): 252–258.
- Link H, Huang YM. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol. 2006; 180(1-2): 17–28.
- Gastaldi M, Zardini E, Leante R, et al. Cerebrospinal fluid analysis and the determination of oligoclonal bands. Neurol Sci. 2017; 38(Suppl 2): 217–224.
- Pryce G, Baker D. Oligoclonal bands in multiple sclerosis; Functional significance and therapeutic implications. Does the specificity matter? Mult Scler Relat Disord. 2018; 25: 131–137.
- Lo Sasso B, Agnello L, Bivona G, et al. Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update. Medicina (Kaunas). 2019; 55(6).
